Skip to main content

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

About Jeffrey Rona

Jeffrey Rona is recorded as CFO and Chief Accounting Officer at Ovid Therapeutics Inc. (OVID). The proxy statement of Ovid Therapeutics Inc. reports total compensation of $969,164 for Jeffrey Rona in fiscal 2025, including a base salary of $506,892. Disclosed compensation is on record for 6 fiscal years.

Summary generated from SEC filings and earnings-call records held by Equibles.

Affiliation history

Recorded current and former roles; source labels appear when available.

Company network

Recorded roles and call appearances connecting this person to public companies.

Leadership on record at Ovid Therapeutics Inc.

Other people whose current roles at this company are on record from its filings.

Executive compensation

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year Company Salary Total
2025 Ovid Therapeutics Inc. (OVID) $506,892 $969,164
2024 Ovid Therapeutics Inc. (OVID) $492,128 $1,518,796
2023 Ovid Therapeutics Inc. (OVID) $469,257 $1,061,098
2022 Ovid Therapeutics Inc. (OVID) $473,200 $1,609,368
2021 Ovid Therapeutics Inc. (OVID) $455,000 $973,317
2020 Ovid Therapeutics Inc. (OVID) $107,860 $1,989,076

Recent activity

No call appearances or filed executive changes recorded yet.